Heparin-Free Prolonged Intermittent Hemodialysis Using Calcium-Free Citrate Dialysate in Critically Ill Patients

被引:23
作者
Faguer, Stanislas [1 ,2 ,3 ]
Saint-Cricq, Morgane [1 ]
Nogier, Marie-Beatrice [1 ]
Labadens, Isabelle [4 ]
Lavayssiere, Laurence [1 ]
Kamar, Nassim [1 ,2 ]
Cointault, Olivier [1 ]
机构
[1] CHU Toulouse, Hop Rangueil, Unite Reanimat, Dept Nephrol & Transplantat Organes, Toulouse, France
[2] Univ Toulouse 3, Toulouse, France
[3] INSERM, U1048, Equipe 12, I2MC, Toulouse, France
[4] CHU Toulouse, Unite Pharm Clin, Pharmacol Dept, Toulouse, France
关键词
citrate; dialysis; intensive care unit; ionic dialysance; regional anticoagulation; ACUTE KIDNEY INJURY; POLYACRYLONITRILE MEMBRANE; IONIC DIALYSANCE; ANTICOAGULATION; NEPHROLOGY; DIALYZER; SOCIETY; BIOFILTRATION; DEGRANULATION; ACTIVATION;
D O I
10.1097/CCM.0000000000002694
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Critically ill patients who have a high risk of bleeding but require prolonged intermittent dialysis need a heparin-free easy-to-use alternative type of anticoagulation within the dialysis circuit. We assessed the safety and efficiency of heparin-free regional citrate anticoagulation of the dialysis circuit using a calcium-free citrate-containing dialysate, with calcium reinjected according to ionic dialysance. Design: Prospective cohort study. Setting: Critical care units. Patients: Critically ill patients who required renal replacement therapy. Interventions: None. Measurements and Main Results: A total of 101 dialysis sessions were performed in 35 patients (mechanical ventilation n = 78; norepinephrine n = 13). Median duration of dialysis was 294 minutes (interquartile range, 240-300), and median ultrafiltration volume was 2.3 L (1-2.8). Urea and beta 2-microglobulin reduction rates were 64.5% +/- 0.4% and 48% +/- 0.13%, respectively. Post-filter ionized calcium was 0.35 +/- 0.17 and 0.38 +/- 0.14 mmol/L at 1 and 3 hours, respectively, within the extracorporeal circuit. A major clotting event that led to premature termination of the session occurred in only three of 101 sessions. In these three cases, major catheter dysfunction occurred before clotting within the circuit. Prefilter ionized calcium remained within narrow ranges (before/after change +0.07 +/- 0.006 mmol/L), and total-to-ionized calcium ratio, a surrogate marker for citratemia, was unchanged. Conclusions: Dialysis anticoagulation with calcium-free citratecontaining dialysate and calcium reinjection according to ionic dialysance is an easy-to-use, efficient, and inexpensive form of heparin-free regional anticoagulation. It allows prolonged hemodialysis sessions in critically ill patients without the need to systemically monitor ionized calcium. Furthermore, sessions can be safely extended according to the hemodynamic tolerance to ensure an adequate dose of dialysis and a negative water balance, a major point in patients with severe acute kidney disease.
引用
收藏
页码:1887 / 1892
页数:6
相关论文
共 33 条
[1]  
Amore A, 2006, J NEPHROL, V19, P57
[2]  
[Anonymous], 2012, Kidney Int Suppl (2011), V2, P89
[3]   Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury [J].
Bagshaw, Sean M. ;
Darmon, Michael ;
Ostermann, Marlies ;
Finkelstein, Fredric O. ;
Wald, Ron ;
Tolwani, Ashita J. ;
Goldstein, Stuart L. ;
Gattas, David J. ;
Uchino, Shigehiko ;
Hoste, Eric A. ;
Gaudry, Stephane .
INTENSIVE CARE MEDICINE, 2017, 43 (06) :841-854
[4]  
Bohler J, 1996, J AM SOC NEPHROL, V7, P234
[5]   What are the anticoagulation options for intermittent hemodialysis? [J].
Davenport, Andrew .
NATURE REVIEWS NEPHROLOGY, 2011, 7 (09) :499-508
[6]   Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: A prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding [J].
Evenepoel, Pieter ;
Dejagere, Tom ;
Verhamme, Peter ;
Claes, Kathleen ;
Kuypers, Dirk ;
Bammens, Bert ;
Vanrenterghem, Yves .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (05) :642-649
[7]   Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology [J].
Fiaccadori, Enrico ;
Pistolesi, Valentina ;
Mariano, Filippo ;
Mancini, Elena ;
Canepari, Giorgio ;
Inguaggiato, Paola ;
Pozzato, Marco ;
Morabito, Santo .
JOURNAL OF NEPHROLOGY, 2015, 28 (02) :151-164
[8]   Regional hemodialysis anticoagulation: Hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A [J].
Flanigan, MJ ;
Pillsbury, L ;
Sadewasser, G ;
Lim, VS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (04) :519-524
[9]   Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study [J].
Francois, Karlien ;
Wissing, Karl Martin ;
Jacobs, Rita ;
Boone, Dries ;
Jacobs, Kristine ;
Tielemans, Christian .
BMC NEPHROLOGY, 2014, 15
[10]   Post-Dilution HemodiafiltrationWith a Heparin-Grafted Polyacrylonitrile Membrane [J].
Frasca, Giovanni M. ;
Sagripanti, Sibilla ;
D'Arezzo, Mario ;
Oliva, Simonetta ;
Francioso, Angelo ;
Mosconi, Giovanni ;
Zambianchi, Loretta ;
Sopranzi, Franco ;
Boggi, Rolando ;
Fattori, Laura ;
Rigotti, Angelo ;
Maldini, Laura ;
Gattiani, Andrea ;
Del Rosso, Goffredo ;
Federico, Antonio ;
Da Lio, Lidia ;
Ferrante, Luigi .
THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (02) :154-161